Lantheus Holdings Inc. is a leading pharmaceutical company based in the United States, specializing in diagnostic products for the healthcare sector. With a strong focus on ESG factors, Lantheus offers Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships to assist healthcare professionals in disease detection and treatment. Despite its high risk rating score of 31.2, Lantheus is committed to promoting sustainability and governance in the pharmaceutical industry.